Highlights the emergence of new indications for cardiac pacing beyond bradycardia and the rapid advancement of pacemaker technology to optimize pacing for these patients.
Answers are grounded in this paper and cite their sources.
May expand pacing indications beyond bradycardia; leaves open prospective validation of advancing technologies.
In the past decade new indications for cardiac pacing have emerged. Remarkably, most of these conditions are not associated with bradycardia1-4. New indications include marked first-degree AV block, malignant vasovagal syncope, obstructive hypertrophic cardiomyopathy, end-stage dilated cardiomyopathy (poor systolic left ventricular function) with congestive heart failure, and paroxysmal atrial fibrillation. Pacemaker technology has continued to advance rapidly in many directions (Table 1) and has also focused on the development of systems to provide optimal pacing in many of the patients with the new indications.
No takes yet. Share an insight, caveat, or question.
Barold et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: